Mincheng Yu

Hubei University of Medicine — China

Medicine · Health Sciences

18h-index945citations52works6.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(16), Cancer, Hypoxia, and Metabolism(7), Ferroptosis and cancer prognosis(7), RNA modifications and cancer(7), MicroRNA in disease regulation(6)

Publications52 total

Galectin-4 drives anti-PD-L1/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma
Gut·2025· 3 cited
PARG inhibition halts cholangiocarcinoma progression via the Hippo pathway and enhances response to chemotherapy and immunotherapy
Journal of Hepatology·2025· 1 cited
Liver regeneration–associated hepatocellular YAP1 activation prevents colorectal cancer liver metastasis through glutamine competition
Science Advances·2025· 2 citedOpen Access
Response and Failure Behavior of Square Tubes with Varying Outer Side Lengths Under Cyclic Bending in Different Directions
Metals·2025Open Access
SIRPα blockade therapy potentiates immunotherapy by inhibiting PD-L1+ myeloid cells in hepatocellular carcinoma
Cell Death and Disease·2025· 2 citedOpen Access
Analgesic treatment of refractory cancer pain caused by bone and soft tissue metastasis of lower esophageal and cardial adenocarcinoma: A case report
Medicine·2025· 2 citedOpen Access
FMO2<sup>+</sup> cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma
Journal for ImmunoTherapy of Cancer·2025· 6 citedOpen Access
Mechanical Tensile Behaviors of Sn-Bi Lead-Free Solder Alloys Under Different Strain Rates and Temperatures
2025
Supplementary Data from ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis
2025Open Access
Data from ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis
2025· 1 citedOpen Access
An Aptamer-guided Nanovesicle Delivery Platform Enables Transcriptome Modulation and Chemosensitivity in Cholangiocarcinoma
HPB·2025
ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis
Cancer Research·2024· 22 cited
GOLM1 dictates acquired Lenvatinib resistance by a GOLM1-CSN5 positive feedback loop upon EGFR signaling activation in hepatocellular carcinoma
Oncogene·2024· 4 cited
SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion
OncoImmunology·2024· 5 citedOpen Access
High Acceleration Dynamic Methodology for Board-Level Shock Solder Joint Reliability Approach
2024· 1 cited
CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma
Journal of Hepatology·2024· 49 citedOpen Access
CYP1B1 promotes colorectal cancer liver metastasis by enhancing the growth of metastatic cancer cells via a fatty acids-dependent manner
Journal of Gastrointestinal Oncology·2023· 10 citedOpen Access
Failure of Elliptical Tubes with Different Long–Short Axis Ratios under Cyclic Bending in Different Directions
Metals·2023· 3 citedOpen Access
Data from IFNα Potentiates Anti–PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment
2023· 1 citedOpen Access
Abstract 814: Novel strategy for aptamer-directed nanovesicle targeting in cholangiocarcinoma
Cancer Research·2023
page 1 of 3Next →

Frequent Co-authors

Jia Fan(23), Qing‐Hai Ye(21), Yong‐Sheng Xiao(18), Binghai Zhou(14), Jiuliang Yan(14), Yongfeng Xu(14), Peiyi Xie(14), Pei‐Yao Fu(13), Zheng Chen(13), Hui‐Chuan Sun(11), Hui Li(10), Bo Hu(9), Jian Zhou(9), Zhangfu Yang(9), Mien‐Chie Hung(9), Cheng Huang(7), Xiaoqiang Li(7), Jian Zhou(7), Yongfeng Xu(7), Chenhao Zhou(6)